# CANC holdings: all 57 positions

> All 57 CANC holdings with weights, as of Oct 13, 2026. The top 3 are RVMD 5.63%, MRK 5.44% and LLY 4.85%. Download the full list as a CSV.

Data as of Oct 13, 2026. Rebuilt every trading night.

CANC held 57 positions as of Oct 13, 2026. Revolution Medicines Inc is the largest at 5.63%; the top 10 are 41.9% of the fund.

Source: Tema (https://temaetfs.com/hubfs/Website/Holdings/CANC-holdings-10132026.csv).

| # | Holding | Ticker | Weight |
| --- | --- | --- | --- |
| 1 | Revolution Medicines Inc | RVMD | 5.63% |
| 2 | Merck & Co Inc | MRK | 5.44% |
| 3 | Eli Lilly & Co | LLY | 4.85% |
| 4 | Cogent Biosciences Inc | COGT | 4.38% |
| 5 | Novartis AG | NOVN | 3.98% |
| 6 | Genmab A/S (ADR) | GMAB | 3.76% |
| 7 | BeOne Medicines Ltd | ONC | 3.53% |
| 8 | AbbVie Inc | ABBV | 3.51% |
| 9 | Halozyme Therapeutics Inc | HALO | 3.45% |
| 10 | Exelixis Inc | EXEL | 3.41% |
| 11 | Iovance Biotherapeutics Inc | IOVA | 3.36% |
| 12 | Roche Holding AG | RHHBY | 2.81% |
| 13 | Bridgebio Pharma Inc | BBIO | 2.74% |
| 14 | Bristol-Myers Squibb Co | BMY | 2.68% |
| 15 | Ideaya Biosciences Inc | IDYA | 2.49% |
| 16 | CG oncology Inc | CGON | 2.47% |
| 17 | Enliven Therapeutics Inc | ELVN | 2.29% |
| 18 | Immunome Inc | IMNM | 2.28% |
| 19 | Astrazeneca PLC | AZN | 2.18% |
| 20 | Johnson & Johnson | JNJ | 2.14% |
| 21 | Erasca Inc | ERAS | 2.00% |
| 22 | Legend Biotech Corp | LEGN | 1.94% |
| 23 | Relay Therapeutics Inc | RLAY | 1.94% |
| 24 | Zai Lab Ltd | ZLAB | 1.74% |
| 25 | Summit Therapeutics Inc | SMMT | 1.62% |
| | Cash and other net assets | | 1.61% |

The largest 25 of 57 positions are shown. All of them: https://etfiq.com/funds/canc/holdings/canc-holdings.csv (CSV) or https://etfiq.com/data/books/canc.json (JSON).

Fund page: https://etfiq.com/funds/canc

Cite: ETFIQ, Holdings of CANC, data as of Oct 13, 2026. https://etfiq.com/funds/canc/holdings/